vimarsana.com

Page 112 - நுகர்வோர் ப்ராடக்ட்ஸ் மற்றும் சேவைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Renesas and Dialog Semiconductor to Join Forces to Advance Global Leadership in Embedded Solutions

Press release content from Business Wire. The AP news staff was not involved in its creation. Renesas and Dialog Semiconductor to Join Forces to Advance Global Leadership in Embedded Solutions February 8, 2021 GMT TOKYO & LONDON (BUSINESS WIRE) Feb 8, 2021 Renesas Electronics Corporation (“Renesas”, TSE: 6723), a supplier of advanced semiconductor solutions, and Dialog Semiconductor Plc (“Dialog”, XETRA:DLG ), a provider of power management, charging, AC/DC power conversion, Wi-Fi and Bluetooth® low energy (BLE) technology, today announced they have reached an agreement on the terms of a recommended all-cash acquisition by Renesas of the entire issued and to be issued share capital of Dialog (the “Acquisition”) for EUR 67.50 per share, representing a total equity value of approximately EUR 4.9 billion (approximately 615.7 billion yen).

UKONIQ™ (umbralisib) Now Approved by the FDA; Onco360® Selected as Exclusive Specialty Pharmacy Partner

Press release content from Business Wire. The AP news staff was not involved in its creation. UKONIQ™ (umbralisib) Now Approved by the FDA; Onco360® Selected as Exclusive Specialty Pharmacy Partner February 8, 2021 GMT LOUISVILLE, Ky. (BUSINESS WIRE) Feb 8, 2021 Onco360 ®, the nation’s largest independent Oncology Pharmacy, has been selected by TG Therapeutics, Inc. to be the exclusive specialty pharmacy partner for UKONIQ TM (umbralisib), a new oral treatment for adult patients with relapsed refractory marginal zone lymphoma who have received at least one prior anti-CD20-based regimen and relapsed refractory follicular lymphoma who have received at least three prior lines of systemic therapy. These indications are approved under accelerated approval based on overall response rate. Continued approval for these indications may be contingent upon verification and description of clinical benefit in a confirmatory trial.

Grown Rogue Acquires Strategic Assets from Acreage Holdings Inc Bringing Total Indoor Capacity to 127,000 Sq Ft

Press release content from Business Wire. The AP news staff was not involved in its creation. Grown Rogue Acquires Strategic Assets from Acreage Holdings Inc. Bringing Total Indoor Capacity to 127,000 Sq Ft February 8, 2021 GMT MEDFORD, Ore. (BUSINESS WIRE) Feb 8, 2021 Grown Rogue International Inc. (“Grown Rogue” or the “Company”) (CSE: GRIN) (OTC: GRUSF), a multi-state cannabis company with operations and assets in Oregon and Michigan, announced today that its subsidiary, Grown Rogue Distribution, LLC, has signed a Definitive Agreement (“ Agreement ”) and Management Services Agreement (“ MSA ”) with HSCP, LLC, (“ HSCP ”) a subsidiary of Acreage Holdings Inc. (CSE:ACRG.A.U, ACRG.B.U) (OTC: ACRHF, ACRDF) effective February 5, 2021 for a previously operational, state-of-the-art 30,000 Sq Ft indoor facility located in Medford, Oregon, and a fully operational retail dispensary in Portland, Oregon. The acquisition brings Grown Rogue’s total indoor capacit

Mytheresa Announces Second Quarter Fiscal Year 2021 Earnings Release and Conference Call; Participating in Upcoming Investor Conferences

Press release content from Business Wire. The AP news staff was not involved in its creation. Mytheresa Announces Second Quarter Fiscal Year 2021 Earnings Release and Conference Call; Participating in Upcoming Investor Conferences February 8, 2021 GMT MUNICH (BUSINESS WIRE) Feb 8, 2021 MYT Netherlands Parent B.V. (NYSE:MYTE) (“Mytheresa”), the parent company of Mytheresa Group GmbH, today announced the date for the release of its second quarter fiscal year 2021 financial results and its participation at upcoming investor conferences. Second Quarter Fiscal Year 2021 Earnings Call and Webcast Mytheresa will release second quarter fiscal year 2021 financial results before the U.S. market open on February 25, 2021. A conference call to discuss its results will follow at 8:00am Eastern Time that same day.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.